Testing effectiveness (Phase 2)Study completedNCT01998958
What this trial is testing
Evaluate the Safety and Efficacy of Intranasal Esketamine in Treatment-resistant Depression
Who this might be right for
Treatment Resistant Depressive Disorder
Janssen Research & Development, LLC 108